Gossamer Bio Future Growth
Future criteria checks 1/6
Gossamer Bio is forecast to grow earnings and revenue by 23.5% and 17.1% per annum respectively while EPS is expected to grow by 29% per annum.
Key information
23.5%
Earnings growth rate
29.0%
EPS growth rate
Biotechs earnings growth | 30.3% |
Revenue growth rate | 17.1% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 16 Aug 2024 |
Recent future growth updates
Recent updates
Brokers Are Upgrading Their Views On Gossamer Bio, Inc. (NASDAQ:GOSS) With These New Forecasts
Aug 14Peaking Back In On Gossamer Bio
Sep 27Gossamer Bio to raise $120M in a private equity placement
Jul 13Health Check: How Prudently Does Gossamer Bio (NASDAQ:GOSS) Use Debt?
Jun 25Gossamer Bio (NASDAQ:GOSS) Has Debt But No Earnings; Should You Worry?
Jan 19Is Gossamer Bio (NASDAQ:GOSS) A Risky Investment?
Sep 22Need To Know: Gossamer Bio, Inc. (NASDAQ:GOSS) Insiders Have Been Buying Shares
Jan 28Gossamer Bio (GOSS) Investor Presentation - Slideshow
Nov 18Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 62 | -123 | -14 | -104 | 8 |
12/31/2025 | 17 | -178 | -99 | -131 | 8 |
12/31/2024 | 117 | -71 | 12 | 12 | 8 |
6/30/2024 | 96 | -81 | -4 | -4 | N/A |
3/31/2024 | N/A | -173 | -158 | -158 | N/A |
12/31/2023 | N/A | -180 | -159 | -159 | N/A |
9/30/2023 | N/A | -187 | -174 | -173 | N/A |
6/30/2023 | N/A | -207 | -176 | -176 | N/A |
3/31/2023 | N/A | -221 | -187 | -187 | N/A |
12/31/2022 | N/A | -229 | -188 | -187 | N/A |
9/30/2022 | N/A | -230 | -180 | -180 | N/A |
6/30/2022 | N/A | -231 | -186 | -185 | N/A |
3/31/2022 | N/A | -234 | -184 | -183 | N/A |
12/31/2021 | N/A | -234 | -191 | -189 | N/A |
9/30/2021 | N/A | -242 | -192 | -185 | N/A |
6/30/2021 | N/A | -240 | -195 | -188 | N/A |
3/31/2021 | N/A | -247 | -205 | -183 | N/A |
12/31/2020 | N/A | -243 | -201 | -176 | N/A |
9/30/2020 | N/A | -233 | -205 | -184 | N/A |
6/30/2020 | N/A | -224 | -197 | -175 | N/A |
3/31/2020 | N/A | -202 | -178 | -169 | N/A |
12/31/2019 | N/A | -180 | -151 | -145 | N/A |
9/30/2019 | N/A | -164 | -130 | -126 | N/A |
6/30/2019 | N/A | -165 | -119 | -105 | N/A |
3/31/2019 | N/A | -154 | -108 | -75 | N/A |
12/31/2018 | N/A | -147 | -72 | -51 | N/A |
9/30/2018 | N/A | -115 | -53 | -32 | N/A |
6/30/2018 | N/A | -66 | -27 | -16 | N/A |
3/31/2018 | N/A | -33 | N/A | -9 | N/A |
12/31/2017 | N/A | -7 | N/A | -6 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: GOSS is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: GOSS is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: GOSS is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: GOSS's revenue (17.1% per year) is forecast to grow faster than the US market (8.8% per year).
High Growth Revenue: GOSS's revenue (17.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if GOSS's Return on Equity is forecast to be high in 3 years time